81
Participants
Start Date
February 3, 2022
Primary Completion Date
January 2, 2024
Study Completion Date
January 2, 2024
Garadacimab
Participants received garadacimab intravenous (IV) loading dose followed by 3 subcutaneous (SC) doses.
Placebo
Participants received a matching placebo IV loading dose, followed by 3 SC doses.
Universitair Ziekenhuis (UZ) Leuven, Leuven
Centre Hospitalier Universitaire Sart Tilman, Liège
Kepler Universitätsklinikum, Linz
Royal Adelaide Hospital, Adelaide
Odense Universitetshospital - Lungemedicinsk Forskningsenhed, Odense
Medizinische Univerität Graz, Graz
Weill Cornell Medical Center, New York
Hospital Universitario Puerta del Mar (HUPM), Cadiz
Temple University TMS, Philadelphia
Jadestone Clinical Research, Silver Spring
Southeastern Research Center, Winston-Salem
Superior Clinical Research, Smithfield
Medizinische Hochschule Hannover - Klinik für Pneumologie, Hanover
Central Florida Pulmonary Group, PA, Orlando
Lakes Research, Miami Lakes
Reliant Medical Research, Miami
US Associates in Research LLC, Miami
Meris Clinical Research, Brandon
Renstar Medical Research, Ocala
The University of Alabama at Birmingham, Birmingham
Clinical Trial Center of Middle Tennesse, Franklin
Petrus Krankenhaus Wuppertal, Wuppertal
Universitaetsklinikum Essen - Ruhrlandklinik (Westdeutsches Lungenzentrum), Essen
University of Cincinnati, Cincinnati
Hannibal Clinic, Hannibal
University of Kansas Medical Center, Kansas City
Azienda Ospedaliera Universitaria Ospedali Riuniti Foggia, Foggia
University of Oklahoma Health Sciences Center, Oklahoma City
Elite Medical Research, Dallas
Southwest Family Medicine Associates, Dallas
Baylor Scott and White Health - Advanced Lung Disease Specialists, Dallas
Baylor College of Medicine, Houston
Pulmonary Associates Clinical Trials AZ, Phoenix
University of Southern California - Center for Advanced Lung Disease, Los Angeles
National Institute of Clinical Research, Huntington Beach
University of California Irvine, Orange
St. Joseph's Healthcare Hamilton, Hamilton
Dr. Syed Anees Medicine Professional Corporation, Windsor
Fachkrankenhaus Coswig GmbH, Coswig
Centrum Medycyny Oddechowej Bialymstoku, Bialystok
Twoja Przychodnia Centrum Medyczne Nowa Sol, Nowa Sól
Centrum Badań Klinicznych NZOZ, Wroclaw
Giromed Institute, SLP, Barcelona
The Churchill Hospital - Oxford University Hospitals NHS Trust, Oxford
Queen Elizabeth Hospital, Birmingham
Altnagelvin Area Hospital, Londonderry
Manchester Univ NHS - Wythenshawe Hospital, Manchester
Lead Sponsor
CSL Behring
INDUSTRY